Refine by
Long Term Hemodialysis Suppliers & Manufacturers
5 companies found
based inFoshan City, CHINA
Established in 1999, Baihe Medical is one of the leading medical device manufacturers in the South of China, specialized in medical disposables for use in anesthesia, blood purification, infusion and wound care. Guangdong Baihe Medical Technology ...
Soft tip; Tapered tip facilitates ease of insertion without use of peel-away sheath. Reduces vessel trauma during ...
based inSalt Lake City, UTAH (USA)
At Health Line, our mission is to be one of the world’s leading manufacturers of vascular access, infusion therapy, and infection control products. We are committed to upholding strong quality management and regulatory systems to meet the demands of ...
Permanent Silicone Hemodialysis Catheters for Chronic Dialysis Therapy. Health Line’s CASCADETM tunneled dialysis catheter kits come in a variety of lengths and kit configurations. Intended for ...
based inHarleysville, PENNSYLVANIA (USA)
Medcomp develops, manufactures, markets and supports cutting-edge vascular access devices and accessories to meet the clinical needs of the medical industry, particularly in the fields of interventional medicine and dialysis. Our company's ...
The Tesio Catheter allows vascular access in adult patients requiring hemodialysis or apheresis who do not have functional permanent vascular access or are not candidates for permanent vascular access. The catheter can act as a bridge device until ...
based inSouth Jordan, UTAH (USA)
Founded in 1987, Merit Medical Systems, Inc. is a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical ...
Central venous stenosis is a common and serious vascular complication among long-term hemodialysis patients that can lead to the loss of vascular access and a diminished life expectancy. The HeRO ...
based inStillwater, MINNESOTA (USA)
Vascudyne is developing, manufacturing and commercializing regenerative acellular in-vitro grown “allograft” tissue. We are visionaries and realists in the right proportions. We are after the holy grail of bringing tissue-engineered medical products ...
Synthetic vascular grafts currently used in clinic have poor long term outcomes and low patency rates. Hyperplasia, calcification, foreign body immune response, infection, and atheroma formation are commonly encountered limiting the use of synthetic ...